Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plecanatide in pediatric IBS-C
NCT03596905Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jun 2018
- Primary completion
- Nov 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plecanatide in irritable bowel syndrome (IBS), sponsored by Valeant Pharmaceuticals. Started Jun 2018; status: completed.
02
Drugs
plecanatide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT03596905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03596905.